Clinical Trial Update: Schizophrenic Patients in Integrated Care [Phase 4]

View source ↗

Summary

Phase 4 clinical trial sponsored by AstraZeneca evaluating schizophrenia-related conditions was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: TERMINATED | Results posted: 2012-07-30